Linkedin Facebook Instagram X-twitter
Main Menu
PRESENTATION
PARTNER WITH US
MENU
Main Menu
PRESENTATION
SUBSCRIBE
Linkedin Facebook Instagram X-twitter
OUR MARKETS

One Platform.
Multiple Healthcare Markets.

ALZAI transforms routine healthcare data into disease-specific risk insights,
helping healthcare providers, health plans, clinical research organizations,
pharmaceutical companies and preventive health programs identify and
prioritize high-risk populations earlier.

CLINICAL TRIALS

Find the Right Patients Earlier

Clinical trial recruitment remains a major challenge, with high screen failure
rates increasing costs and extending timelines. ALZAI uses disease-specific AI models to identify higher-probability candidates from routine healthcare data, enabling more targeted pre-screening, better patient enrichment and more efficient recruitment for sponsors, CROs and research sites.
→ Learn More About Our Clinical Trial Solutions

PHARMA

Turn Population Data Into
Patient-Finding Intelligence

Identifying the right patients remains a challenge throughout the
pharmaceutical product lifecycle, particularly in diseases that often go
undiagnosed for years. ALZAI uses disease-specific AI models to identify
high-risk populations from routine healthcare data, supporting more targeted patient identification during clinical development and helping pharmaceutical companies uncover underdiagnosed populations as therapies move toward commercialization.
→ Learn More About Our Pharma Solutions

HEALTH PLANS

Identify Risk Earlier
Across Member Populations

Health plans manage large member populations, yet individuals at elevated
risk for chronic diseases often remain unidentified until diagnosis or disease progression. ALZAI uses disease-specific AI models to stratify members using existing healthcare data, enabling earlier risk identification, more targeted care management and better resource allocation. The platform also supports payer-specific workflows, including Medicare Advantage RAF (Risk Adjustment Factors).
→ Learn More About Our Health Plan Solutions

HEALTH SYSTEMS & EMR

Turn Existing Healthcare Data
Into Actionable Risk Insights

Health systems hold extensive patient data, yet identifying individuals at
elevated disease risk remains challenging, particularly when conditions
progress silently for years. ALZAI applies disease-specific AI models to
existing healthcare data, enabling earlier risk identification and more targeted patient prioritization. These insights can be integrated into existing clinical workflows without requiring separate screening processes..
→ Learn More About Our Health System Solutions

LONGEVITY & DIGITAL HEALTH

Bring Disease-Risk Intelligence
Into Preventive Health

Longevity clinics and digital health platforms aim to identify health risks before disease progresses, but often lack scalable, disease-specific tools. ALZAI uses existing healthcare data to identify individuals at elevated risk, enabling more personalized preventive care, targeted clinical evaluation and seamless integration into existing health programs without requiring additional screening pathways.
→ Learn More About Our Longevity & Digital Health Solutions
ONE PLATFORM. MULTIPLE APPLICATIONS.

Built to Work Across the Healthcare Ecosystem

ALZAI’s scalable platform is designed to bring disease-specific risk stratification into different healthcare environments – supporting clinical research, pharmaceutical companies, health plans, health systems and preventive health programs.
Different markets. Different workflows. One underlying platform designed
to turn existing healthcare data into actionable disease-risk insights.
PARTNER WITH US →
Population review · Clipboard and magnifier
Clinical Trials
Pharmaceutical manufacturing · Medicines
Pharma
Protected care plan · Clipboard and shield
Health Plans
Digital medical records · Monitor
Health Systems & EMR
Preventive heart health · Heartbeat
Longevity & Digital Health